Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $203.9 million.

  • Select Medical Holdings' Depreciation & Amortization (CF) fell 3131.24% to $34.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.8 million, marking a year-over-year decrease of 2936.53%. This contributed to the annual value of $203.9 million for FY2024, which is 232.25% down from last year.
  • Select Medical Holdings' Depreciation & Amortization (CF) amounted to $203.9 million in FY2024, which was down 232.25% from $208.7 million recorded in FY2023.
  • In the past 5 years, Select Medical Holdings' Depreciation & Amortization (CF) ranged from a high of $208.7 million in FY2023 and a low of $202.6 million during FY2021
  • Over the past 5 years, Select Medical Holdings' median Depreciation & Amortization (CF) value was $205.7 million (recorded in 2020), while the average stood at $205.4 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first plummeted by 325.39% in 2020, then soared by 156.92% in 2022.
  • Annual analysis of 5 years shows Select Medical Holdings' Depreciation & Amortization (CF) stood at $205.7 million in 2020, then fell by 1.47% to $202.6 million in 2021, then grew by 1.57% to $205.8 million in 2022, then rose by 1.42% to $208.7 million in 2023, then fell by 2.32% to $203.9 million in 2024.
  • Its Depreciation & Amortization (CF) was $203.9 million in FY2024, compared to $208.7 million in FY2023 and $205.8 million in FY2022.